Study
Insulin Glargine and Lantus(R) Trial 2 Insulin Glargine and Lantus(R) Trial 2 - Daytona Beach , FL - #CCRI11628
Summary

To test the effectivness, safety, and tolerability of a new formulation of Insulin Glargine and Lantus(R) for Type 2 Diabetes

Qualifications - Inclusions & Exclusions

Inclusion
Type 2 Diabetes
Age 18 or Older

Exclusions:
Hemoglobin A1c between 7 and 10 at screening
Diabetes other than Type 2
Use of Insulin pump in the last 6 months before screening visit
History of drug or alcohol abuse within 6 months prior to screening

Compensation for Time and Travel

Participants who qualify will receive reimbursement for their time and participation for an amount up to $640

Location
Daytona Beach, Volusia County
Daytona Beach, FL 32117
In/Outpatient
Outpatient
Submit the form below to learn more

* Denotes required field.

First Name * Required
Last Name
Comments
First Name *
Last Name *
Email *
Daytime Phone
Evening Phone
Source
If Other
Comments
   Privacy Policy